Drug Profile
Research programme: ATP-binding cassette transporter activators for organ toxicity in immunosuppression - Limerick BioPharma
Alternative Names: LIM-0723Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Limerick BioPharma
- Class Small molecules
- Mechanism of Action ATP-binding cassette transporter stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Transplant-rejection(Adjunctive treatment) in USA (PO)